![FDA, FTC and DOJ Enforcement of Medical Device Regulations FDA, FTC and DOJ Enforcement of Medical Device Regulations](https://www.fdanews.com/ext/resources/Book-Covers-2/BFFDEMDR-COVER.png?height=200&t=1685733565&width=200)
Home » Health Canada to Offer Preclinical Meetings to Devicemakers
Health Canada to Offer Preclinical Meetings to Devicemakers
![HealthCanada_Logo.gif](https://www.fdanews.com/ext/resources/test/Drug-Images2/HealthCanada_Logo.gif?t=1576125138&width=430)
Health Canada is launching a pilot program to offer preclinical advice to devicemakers on their investigational testing protocols for new products.
The agency hopes the new program — under Health Canada’s Regulatory Review of Drugs and Devices Initiative — will improve the quality of submissions and provide “more timely regulatory decisions.”
Device manufacturers will be able to contribute to the design of the pre-clinical meetings and guidance material, the agency said.
The pilot program will run from November 2018 to March 2019.
Upcoming Events
-
11Jul
-
18Jul
-
21Oct